BIOMAT Database Logo BIOMAT Database Logo

Pharmacotherapy: vandetanib-a new therapeutic option in advanced medullary thyroid cancer. 2011

Linda Koch

UI MeSH Term Description Entries
D008297 Male Males
D010880 Piperidines A family of hexahydropyridines.
D011799 Quinazolines A group of aromatic heterocyclic compounds that contain a bicyclic structure with two fused six-membered aromatic rings, a benzene ring and a pyrimidine ring. Quinazoline
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013964 Thyroid Neoplasms Tumors or cancer of the THYROID GLAND. Cancer of Thyroid,Thyroid Cancer,Cancer of the Thyroid,Neoplasms, Thyroid,Thyroid Adenoma,Thyroid Carcinoma,Adenoma, Thyroid,Adenomas, Thyroid,Cancer, Thyroid,Cancers, Thyroid,Carcinoma, Thyroid,Carcinomas, Thyroid,Neoplasm, Thyroid,Thyroid Adenomas,Thyroid Cancers,Thyroid Carcinomas,Thyroid Neoplasm

Related Publications

Linda Koch
Vandetanib: opening a new treatment practice in advanced medullary thyroid carcinoma.
October 2013, Endocrine,
Linda Koch
Vandetanib: in medullary thyroid cancer.
July 2012, Drugs,
Linda Koch
Vandetanib and the management of advanced medullary thyroid cancer.
January 2013, Current opinion in oncology,
Linda Koch
Vandetanib: a guide to its use in advanced medullary thyroid cancer.
December 2012, BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy,
Linda Koch
Vandetanib therapy in medullary thyroid cancer.
November 2012, Drugs of today (Barcelona, Spain : 1998),
Linda Koch
Vandetanib (Caprelsa) for medullary thyroid cancer.
January 2012, The Medical letter on drugs and therapeutics,
Linda Koch
Vandetanib: too dangerous in medullary thyroid cancer.
October 2012, Prescrire international,
Linda Koch
Vandetanib in advanced medullary thyroid cancer: review of adverse event management strategies.
November 2013, Advances in therapy,
Linda Koch
Vandetanib for the Management of Advanced Medullary Thyroid Cancer: A Real-World Multicenter Experience.
September 2020, Endocrinology and metabolism (Seoul, Korea),
Linda Koch
Long-term follow-up and safety of vandetanib for advanced medullary thyroid cancer.
February 2021, Endocrine,
Copied contents to your clipboard!